Feb 9, 2026 04:06PM
Aug 11, 2025 11:34AM
Feb 10, 2025 05:29PM
Nov 6, 2024 06:08PM
Sep 19, 2024 05:25AM
Feb 7, 2024 05:33AM
Feb 7, 2024 05:21AM Goldman Sachs Reinstates 4D Molecular Therapeutics (FDMT) at Buy, 'Platform value to inflect via 2024 catalysts'
Feb 6, 2024 11:27PM
Feb 5, 2024 04:05PM
Feb 5, 2024 04:05PM
Jun 1, 2023 08:00AM
May 9, 2023 04:05PM
May 5, 2023 05:43AM
May 4, 2023 09:04PM 4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
May 4, 2023 04:09PM
May 4, 2023 04:08PM
Nov 15, 2022 06:54AM
Jun 2, 2022 04:02PM
Jun 2, 2022 04:02PM
Oct 29, 2021 05:35AM
Oct 28, 2021 09:06PM 4D Molecular Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 28, 2021 09:06PM
Oct 26, 2021 05:52PM
Oct 26, 2021 05:52PM
Jun 3, 2021 07:00AM
Jun 3, 2021 07:00AM
Dec 15, 2020 04:05PM
Dec 11, 2020 12:09PM 4D Molecular Therapeutics (FDMT) IPO Opens 74% Higher
Dec 11, 2020 06:09AM

176,323 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All